CROMA Pharma, GmbH Company Profile
CROMA Pharma, GmbH, is a private global specialty pharmaceutical and surgical company dedicated to improving people’s health through the development and commercialization of innovative products in the ophthalmology, osteoarthritis and aesthetic dermatology fields. Founded in 1976, the company is headquartered in Leobendorf, Austria (near Vienna) and employs approximately 400 individuals at its headquarters and subsidiaries in Austria, Germany, France, Poland, Romania Spain and the USA. Today as a global player CROMA distributes its products in 62 countries via its own commercial sales organization(s), strategic partnerships and distributors. More information is available at www.croma.at.
News Articles
Bausch + Lomb und CROMA spenden dringend benötigte Augentropfen
WIEN , 22. Januar 2013 /- Weltweit sind 39 Millionen Menschen blind. Die häufigste Ursache für Blindheit ist die Katarakt (auch Linsentrübung oder „grauer Star"). Mit einem Antei...
Pharma 3.0 Pulls Companies into the Digital Future
Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0. Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...
Big pharma companies BMS and Merck are pharma partnering on Daclatasvir
Big pharma company, Bristol-Myers Squibb, is pharma partnering with another big pharma company, Merck, to develop Daclatasvir to treat Hepatitis C. The big pharma companies will work on the hepatitis...
Merck enter pharma partnering pact with Ra Pharma for cyclomimetics
Ra Pharmaceuticals has entered into a pharma partnering deal with Merck, a top 50 big pharma corporation, focused on the development of Cyclomimetics, a new class of compounds that have the diversity...
Verona Pharma plc: Analyst Presentation on the Company Website
LONDON, April 10, 2013 /PRNewswire/ -- Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma plc (VRP: London Stock Exchange) ("Verona Pharma", or the "Company"), the biotechnology co...
Big Pharma performance continues to receive muted reviews from various analysts and industry commentators. Pharma Reform starts with an analysis of drug approvals in 2012 by FDA. It is TRUE that 35 dr...
Bad Pharma by Dr Ben Goldacre; the mechanics of a mediocre argument
Nick Broughton discusses Dr Ben Goldacre’s latest book, Bad Pharma, and comments on why he believes it was a wasted opportunity for the pharma industry. If you are working in pharma and are not awa...
Pharma IQ’s Top Pharma Bloggers of 2013
Pharma IQ put out it’s list of the Top Pharma Bloggers for 2013. These lists tend to be subjective and always leave off many great sites. But, these can be a good way to discover a blog you have...
Drugs and Medications
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 0.5 mg
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 1 mg
Metoprolol tartrate [Med-Health Pharma, LLC]
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
PubMed Articles
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
Is pharma running out of brainy ideas?
Clinical Trials
Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers
The "dry eye syndrome" DES is a highly prevalent ocular disease, in particular in the elderly population. One mainstay of therapy for patients suffering from DES is the use of topically ad...
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...
Companies
CROMA Pharma, GmbH, is a private global specialty pharmaceutical and surgical company dedicated to improving people’s health through the development and commercialization of...
H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...
Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...
More Information about "CROMA Pharma, GmbH" on BioPortfolio
We have published hundreds of CROMA Pharma, GmbH news stories on BioPortfolio along with dozens of CROMA Pharma, GmbH Clinical Trials and PubMed Articles about CROMA Pharma, GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CROMA Pharma, GmbH Companies in our database. You can also find out about relevant CROMA Pharma, GmbH Drugs and Medications on this site too.